The inspection was carried out between January 14 and January 25, 2019
Lupin announced the completion of the United States Food and Drug Administration (US FDA) inspection carried out at its Pithampur Unit -2 (Indore) facility. The inspection was carried out between January 14 and January 25, 2019.
The inspection at Pithampur Unit-2 (Indore) closed with six observations. The company is confident ofaddressing the observations satisfactorily.